Merck cuts outlook and forecasts hit for Q2

While Pfizer reported its first quarter earnings that beating estimates, Merck says it expects a $2.1 billion hit to its full-year revenue. Yahoo Finance’s Anjalee Khemlani joins the On The Move panel to weigh in.